Hana Pharm KRX:293480KOSPI

하나제약 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days9
DART filings, 7 days0
Articles tracked9since Sep 11

In Q2 2026, Hana Pharm reported revenue of ₩60.9bn, up 5.2% year on year, and operating profit of ₩7.3bn. Hana Pharm (하나제약) appeared in 9 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 8 articles. It was most often mentioned alongside Boryung.

Filing signals Dividend cut Screener

Hana Pharm quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩60.9bn+5.2%₩7.3bn₩8.4bn
Q1 2026₩62.3bn+8.3%₩7.1bn₩10.0bn
Q4 2025 derived₩60.4bn+4.9%₩5.8bn₩3.3bn
Q3 2025₩63.8bn+11.4%₩8.3bn−₩4.3bn
Q2 2025₩57.9bn+8.2%₩6.0bn₩5.5bn
Q1 2025₩57.5bn+0.7%₩5.6bn₩4.2bn
Q4 2024 derived₩57.5bn+0.3%₩8.9bn₩7.2bn
Q3 2024₩57.3bn+3.0%₩3.9bn₩3.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Hana Pharm top stories 2 weeks, by number of outlets

  1. 1
    이삼수 하나제약 사장 차녀 결혼
    7 outlets · 7 articlesFirst report Sep 11 09:50 메디파나뉴스
  2. 2
    이삼수 하나제약 사장 차녀 결혼
    1 outlets · 1 articlesFirst report Sep 14 14:23 의학신문(보사)
  3. 3
    [화촉] 이삼수(하나제약 사장·전 보령 대표이사)씨 차녀
    1 outlets · 1 articlesFirst report Sep 11 10:35 더바이오Boryung

Latest Hana Pharm news Korean headlines